In what can be considered a breakthrough in the field of medical technologies, Rebrain’s AI based system for improving brain targeting has received a nod from the U.S Food and Drug Administration (FDA). This breakthrough is a new beginning in the field of neurological treatment, as treatment employing advanced artificial intelligence technologies sees more application […]
